Percent of antibiotics manufacturing sites that meet the AMR Industry Alliance Standard for responsible manufacturing
Unit
: Percentage (%)
Indicator
: Pollutants released to environment
Metric Type
: Pressure
Frameworks alignment notes
Refer to AMR's Progress Survey Results for related metric
Refer to AMR's Shared Goals in the Guidance tab
WHO guidance
Refer to EFPIA's Clear Steps Toward a Greener Future - Pharmaceutical Sector’s Environmental Sustainability Statement (10.06.24) for alignment to metric
T7, T15
Target example
[Company name] will convey Common Antibiotic Manufacturing Framework (CAMF) requirements to [target amount]% of its antibiotic manufacturing sites and key suppliers
Target Source: WBCSD target template
Sector
Pharmaceutical
Value chain stage
Raw MaterialsManufacturing
Metric assessment
Relevance:High
Feasibility:Medium
Related Actions
Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites
Reduce air, water and soil pollution (including non-GHG emissions) from agriculture-related pharmaceutical manufacturing feedstocks by engaging with suppliers and encouraging the adoption of less polluting methods in alignment with a Science Based Targets Network (SBTN) Landscape Engagement Target
Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria